The Independent Voice of
European Private Equity

Advanced Search

Apposite Capital invests €7m in NIMGenetics

Luciano Figari 10 May 2017

Healthcare specialist Apposite Capital has made an initial investment of €7m in NIMGenetics, a genetic diagnostic laboratory based in Spain.

NIMGenetics was created in 2008 and currently serves more than 500 medical centres and around 1,500 clinicians, mainly in Spain and Latin...

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19